Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: JAMA Intern Med. 2015 Apr 1;175(4):531–539. doi: 10.1001/jamainternmed.2014.8063

Figure 2. Kaplan-Meier Estimates of Total VMS Duration of Frequent VMS by Menopausal Transition Stage at First VMS Report (A) and by Race/Ethnicity (B).

Figure 2

A, By menopausal transition stage at first VMS report. B, By race/ethnicity. VMS indicates vasomotor symptoms. Menopausal transition stage at first VMS report is missing for 9 participants. Median duration for each group is calculated as the value on the x-axis corresponding to the intersection of the dashed horizontal line (50%) with the group’s survival curve.

HHS Vulnerability Disclosure